Evidence map›Paper›PMID 29592874›Full record

ArticleRNA (New York, N.Y.)2018

Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis.

Lea Shallev, Eli Kopel, Ariel Feiglin, Gil S Leichner, Dror Avni, Yechezkel Sidi, Eli Eisenberg, Aviv Barzilai, Erez Y Levanon, Shoshana Greenberger

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Psoriasis.Nature reviews. Disease primers · 2025
    Review
  5. Article
  6. Article
  7. ADAR Family Proteins: A Structural Review.Current issues in molecular biology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lea ShallevMina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 52900, Israel.
Eli KopelMina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 52900, Israel.
Ariel FeiglinMina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 52900, Israel.
Gil S LeichnerThe Department of Dermatology, Sheba Medical Center, Tel Hashomer 52621, Israel.
Dror AvniDepartment of Medicine C, Sheba Medical Center, Tel Hashomer 52621, Israel.
Yechezkel SidiSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Eli EisenbergRaymond and Beverly Sackler School of Physics and Astronomy, Tel Aviv University, Tel Aviv 69978, Israel.
Aviv BarzilaiThe Department of Dermatology, Sheba Medical Center, Tel Hashomer 52621, Israel.
Erez Y LevanonMina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 52900, Israel.
Shoshana GreenbergerThe Department of Dermatology, Sheba Medical Center, Tel Hashomer 52621, Israel.
Tel Aviv University · ILBar-Ilan University · ILSheba Medical Center · IL

Funding

European Research Council 311257
6 · The paper itself

Abstract

Recognition of dsRNA molecules activates the MDA5-MAVS pathway and plays a critical role in stimulating type-I interferon responses in psoriasis. However, the source of the dsRNA accumulation in psoriatic keratinocytes remains largely unknown. A-to-I RNA editing is a common co- or post-transcriptional modification that diversifies adenosine in dsRNA, and leads to unwinding of dsRNA structures. Thus, impaired RNA editing activity can result in an increased load of endogenous dsRNAs. Here we provide a transcriptome-wide analysis of RNA editing across dozens of psoriasis patients, and we demonstrate a global editing reduction in psoriatic lesions. In addition to the global alteration, we also detect editing changes in functional recoding sites located in the

Indexed as

RNA, Double-StrandedRNA EditingAdenosineAdolescentAdultAgedAged, 80 and overCase-Control StudiesCells, CulturedConnective Tissue Growth FactorCopper-Transporting ATPasesEscherichia coli ProteinsFemaleFilaminsGene Expression ProfilingHigh-Throughput Nucleotide SequencingAdenosineCCN2 protein, humanConnective Tissue Growth FactorcopA protein, E coliCopper-Transporting ATPasesEscherichia coli ProteinsFilaminsFLNA protein, humanInosineRNA, Double-StrandedA-to-IinterferonpsoriasisRNA editing

Identifiers

PMID29592874
PMCPMC5959251
OpenAlexW2794989402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.